+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Oral Proteins & Peptides Market Research Report by Drug Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4968731
  • Report
  • July 2021
  • Region: Global
  • 194 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Oral Proteins & Peptides Market will Grow to USD 2,043.61 Million by 2026, at a CAGR of 13.18%

FEATURED COMPANIES

  • Allergan Plc.
  • AstraZeneca PLC
  • Biocon Limited
  • Chiasma Inc.
  • Novo Nordisk A/S
  • Proxima Concepts Limited
  • MORE
The Global Oral Proteins & Peptides Market size was estimated at USD 971.92 Million in 2020 and expected to reach USD 1,096.79 Million in 2021, at a Compound Annual Growth Rate (CAGR) 13.18% to reach USD 2,043.61 Million by 2026.



Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Oral Proteins & Peptides to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Drug Type, the Oral Proteins & Peptides Market was examined across Calcitonin, Insulin, Linaclotide, Octreotide, and Plecanatide.
  • Based on Application, the Oral Proteins & Peptides Market was examined across Bone Diseases, Diabetes, Gastric & Digestive Disorders, and Hormonal Disorders.
  • Based on Geography, the Oral Proteins & Peptides Market was examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas was further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific was further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa was further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. This ongoing research amplifies this research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Oral Proteins & Peptides Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Oral Proteins & Peptides Market, including Allergan Plc., AstraZeneca PLC, Biocon Limited, Chiasma Inc., Generex Biotechnology Corp., Novo Nordisk A/S, Oramed Pharmaceuticals Inc., Proxima Concepts Limited, Synergy Pharmaceuticals Inc., and Tarsa Therapeutics Inc.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Oral Proteins & Peptides Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Oral Proteins & Peptides Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Oral Proteins & Peptides Market?
4. What is the competitive strategic window for opportunities in the Global Oral Proteins & Peptides Market?
5. What are the technology trends and regulatory frameworks in the Global Oral Proteins & Peptides Market?
6. What is the market share of the leading vendors in the Global Oral Proteins & Peptides Market?
7. What modes and strategic moves are considered suitable for entering the Global Oral Proteins & Peptides Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Allergan Plc.
  • AstraZeneca PLC
  • Biocon Limited
  • Chiasma Inc.
  • Novo Nordisk A/S
  • Proxima Concepts Limited
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Drug Type Outlook
3.4. Application Outlook
3.5. Geography Outlook
3.6. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in prevalence of chronic diseases
5.1.1.2. Rise in patient preference for oral drugs
5.1.1.3. Growing demand for effective drugs and technology
5.1.2. Restraints
5.1.2.1. High manufacturing costs and low bioavailability
5.1.3. Opportunities
5.1.3.1. Rise in oral peptide and protein therapeutics applications
5.1.3.2. Increase in R&D by pharmaceutical companies
5.1.4. Challenges
5.1.4.1. Concerns related to unwanted enzymatic degradation and inherent structural complexities
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Oral Proteins & Peptides Market, by Drug Type
6.1. Introduction
6.2. Calcitonin
6.3. Insulin
6.4. Linaclotide
6.5. Octreotide
6.6. Plecanatide

7. Oral Proteins & Peptides Market, by Application
7.1. Introduction
7.2. Bone Diseases
7.3. Diabetes
7.4. Gastric & Digestive Disorders
7.5. Hormonal Disorders

8. Americas Oral Proteins & Peptides Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Oral Proteins & Peptides Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Thailand

10. Europe, Middle East & Africa Oral Proteins & Peptides Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Allergan Plc.
12.2. AstraZeneca PLC
12.3. Biocon Limited
12.4. Chiasma Inc.
12.5. Generex Biotechnology Corp.
12.6. Novo Nordisk A/S
12.7. Oramed Pharmaceuticals Inc.
12.8. Proxima Concepts Limited
12.9. Synergy Pharmaceuticals Inc.
12.10. Tarsa Therapeutics Inc.

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2020 (USD MILLION)
FIGURE 3. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 4. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 5. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 6. GLOBAL ORAL PROTEINS & PEPTIDES MARKET: MARKET DYNAMICS
FIGURE 7. GLOBAL ORAL PROTEINS & PEPTIDES MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 8. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2020 VS 2026 (%)
FIGURE 9. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2026
FIGURE 11. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY CALCITONIN, 2018-2026 (USD MILLION)
FIGURE 12. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY CALCITONIN, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 13. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN, 2018-2026 (USD MILLION)
FIGURE 14. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 15. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY LINACLOTIDE, 2018-2026 (USD MILLION)
FIGURE 16. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY LINACLOTIDE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 17. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY OCTREOTIDE, 2018-2026 (USD MILLION)
FIGURE 18. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY OCTREOTIDE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 19. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PLECANATIDE, 2018-2026 (USD MILLION)
FIGURE 20. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PLECANATIDE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 21. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 22. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2026
FIGURE 24. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY BONE DISEASES, 2018-2026 (USD MILLION)
FIGURE 25. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY BONE DISEASES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 26. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DIABETES, 2018-2026 (USD MILLION)
FIGURE 27. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 28. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GASTRIC & DIGESTIVE DISORDERS, 2018-2026 (USD MILLION)
FIGURE 29. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GASTRIC & DIGESTIVE DISORDERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 30. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY HORMONAL DISORDERS, 2018-2026 (USD MILLION)
FIGURE 31. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY HORMONAL DISORDERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 32. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 33. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 35. ARGENTINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 36. BRAZIL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 37. CANADA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 38. MEXICO ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 39. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 40. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 41. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 43. AUSTRALIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 44. CHINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 45. INDIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 46. INDONESIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 47. JAPAN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 48. MALAYSIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 49. PHILIPPINES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 50. SINGAPORE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 51. SOUTH KOREA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 52. THAILAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 53. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 54. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 55. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 56. FRANCE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 57. GERMANY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 58. ITALY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 59. NETHERLANDS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 60. QATAR ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 61. RUSSIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 62. SAUDI ARABIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 63. SOUTH AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 64. SPAIN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 65. UNITED ARAB EMIRATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 66. UNITED KINGDOM ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 67. GLOBAL ORAL PROTEINS & PEPTIDES MARKET: FPNV POSITIONING MATRIX
FIGURE 68. GLOBAL ORAL PROTEINS & PEPTIDES MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 69. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ORAL PROTEINS & PEPTIDES MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL ORAL PROTEINS & PEPTIDES MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY CALCITONIN, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY LINACLOTIDE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY OCTREOTIDE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PLECANATIDE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY BONE DISEASES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GASTRIC & DIGESTIVE DISORDERS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY HORMONAL DISORDERS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 15. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 16. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 17. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 18. ARGENTINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 19. ARGENTINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 20. BRAZIL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 21. BRAZIL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 22. CANADA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 23. CANADA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 24. MEXICO ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 25. MEXICO ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 26. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 27. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 28. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 29. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 30. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 31. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 32. AUSTRALIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 33. AUSTRALIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 34. CHINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 35. CHINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 36. INDIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 37. INDIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 38. INDONESIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 39. INDONESIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 40. JAPAN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 41. JAPAN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 42. MALAYSIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 43. MALAYSIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 44. PHILIPPINES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 45. PHILIPPINES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 46. SINGAPORE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 47. SINGAPORE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 48. SOUTH KOREA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 49. SOUTH KOREA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 50. THAILAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 51. THAILAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 55. FRANCE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 56. FRANCE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 57. GERMANY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 58. GERMANY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 59. ITALY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 60. ITALY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 61. NETHERLANDS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 62. NETHERLANDS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 63. QATAR ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 64. QATAR ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 65. RUSSIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 66. RUSSIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 67. SAUDI ARABIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 68. SAUDI ARABIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 69. SOUTH AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 70. SOUTH AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 71. SPAIN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 72. SPAIN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 73. UNITED ARAB EMIRATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 74. UNITED ARAB EMIRATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 75. UNITED KINGDOM ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 76. UNITED KINGDOM ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 77. GLOBAL ORAL PROTEINS & PEPTIDES MARKET: SCORES
TABLE 78. GLOBAL ORAL PROTEINS & PEPTIDES MARKET: BUSINESS STRATEGY
TABLE 79. GLOBAL ORAL PROTEINS & PEPTIDES MARKET: PRODUCT SATISFACTION
TABLE 80. GLOBAL ORAL PROTEINS & PEPTIDES MARKET: RANKING
TABLE 81. GLOBAL ORAL PROTEINS & PEPTIDES MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 82. GLOBAL ORAL PROTEINS & PEPTIDES MARKET: MERGER & ACQUISITION
TABLE 83. GLOBAL ORAL PROTEINS & PEPTIDES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 84. GLOBAL ORAL PROTEINS & PEPTIDES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 85. GLOBAL ORAL PROTEINS & PEPTIDES MARKET: INVESTMENT & FUNDING
TABLE 86. GLOBAL ORAL PROTEINS & PEPTIDES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 87. GLOBAL ORAL PROTEINS & PEPTIDES MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Allergan Plc.
  • AstraZeneca PLC
  • Biocon Limited
  • Chiasma Inc.
  • Generex Biotechnology Corp.
  • Novo Nordisk A/S
  • Oramed Pharmaceuticals Inc.
  • Proxima Concepts Limited
  • Synergy Pharmaceuticals Inc.
  • Tarsa Therapeutics Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll